(Q40135421)

17 September 2017

A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation (English)

1 reference

17 September 2017

1

1 reference

17 September 2017

3

1 reference

17 September 2017

4

1 reference

17 September 2017

7

1 reference

17 September 2017

9

1 reference

17 September 2017

Joana Figueiredo

6

0 references

José Manuel Lopes

object named as

José Manuel Lopes

series ordinal

8

0 references

author name string

Cátia Moutinho

series ordinal

2

1 reference

PubMed ID

17487504

17 September 2017

Ana Paula Rebocho

series ordinal

5

1 reference

17 September 2017

9 May 2007

1 reference

17 September 2017

8

1 reference

inferred from page(s)

published in

Virchows Archiv

1 reference

17 September 2017

450

1 reference

17 September 2017

6

1 reference

17 September 2017

619-626

1 reference

https://scigraph.springernature.com/pub.10.1007/s00428-007-0420-9

17 September 2017

0 references

cites work

KIT gene mutations in gastrointestinal stromal tumors: more complex than previously recognized?

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00428-007-0420-9

Activating c-kit gene mutations in human germ cell tumors

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00428-007-0420-9

Molecularly targeted therapy for gastrointestinal cancer

21 January 2018

1 reference

12 December 2020

Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the β-catenin signaling activity

1 reference

12 December 2020

KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression

1 reference

12 December 2020

Detection of c-kit exons 11- and 17-activating mutations in testicular seminomas by high-resolution melting amplicon analysis.

1 reference

12 December 2020

Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation

1 reference

12 December 2020

Mutations of the BRAF gene in human cancer

1 reference

12 December 2020

Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers

1 reference

12 December 2020

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

1 reference

12 December 2020

BRAF and c-kit gene copy number in mutation-positive malignant melanoma

1 reference

12 December 2020

Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies

1 reference

12 December 2020

c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens

1 reference

12 December 2020

Somatic activation of KIT in distinct subtypes of melanoma

1 reference

12 December 2020

Effect of platelet-derived growth factor receptor-beta inhibition with STI571 on radioimmunotherapy.

1 reference

12 December 2020

Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential.

1 reference

12 December 2020

c-kit gene mutations in intracranial germinomas

1 reference

12 December 2020

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

12 December 2020

BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency

1 reference

12 December 2020

RAF/RAS oncogenes and mismatch-repair status

1 reference

12 December 2020

Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.

1 reference

12 December 2020

c-kit proto-oncogene product is rarely detected in colorectal adenocarcinoma

1 reference

12 December 2020

Inhibition of cell survival and invasive potential of colorectal carcinoma cells by the tyrosine kinase inhibitor STI571.

1 reference

12 December 2020

Identification of interstitial cells of Cajal in the human rectum

1 reference

12 December 2020

Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors

1 reference

12 December 2020

Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients.

1 reference

12 December 2020

Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1

1 reference

12 December 2020

The biology of stem cell factor and its receptor C-kit

1 reference

12 December 2020

KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes

1 reference

12 December 2020

Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours

1 reference

12 December 2020

Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues.

1 reference

12 December 2020

Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies

1 reference

12 December 2020

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product

1 reference

12 December 2020

Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines

1 reference

12 December 2020

Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases

1 reference

12 December 2020

Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.

1 reference

12 December 2020

PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors

1 reference

12 December 2020

Rapid screening for KIT mutations by capillary electrophoresis

1 reference

12 December 2020

The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.

1 reference

12 December 2020

Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma

1 reference

12 December 2020

Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis

1 reference

12 December 2020

10.1007/S00428-007-0420-9

Identifiers

DOI

1 reference

PubMed ID

17487504

Dimensions Publication ID

17 September 2017

0 references

1 reference

PubMed ID

17487504